Clinical Trials Directory

Trials / Conditions / Chronic Myeloid Leukemia in Chronic Phase

Chronic Myeloid Leukemia in Chronic Phase

5 registered clinical trials studyying Chronic Myeloid Leukemia in Chronic Phase — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingReal-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China
NCT07375355
Novartis Pharmaceuticals—
UnknownThe Efficacy and Safety of Switching to Flumatinib Versus Dasatinib After Imatinib-related Low-grade Adverse E
NCT04933526
Shenzhen Second People's HospitalPhase 4
CompletedStudy of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leuk
NCT03509896
Bristol-Myers Squibb—
TerminatedEfficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phas
NCT00451035
Novartis PharmaceuticalsPhase 2
AvailableManaged Access Programs for ABL001, Asciminib
NCT04360005
Novartis Pharmaceuticals—